533 related articles for article (PubMed ID: 10896983)
1. [Immunomodulatory effects of intravenous immunoglobulins].
Kazatchkine M; Mouthon L; Kaveri SV
Ann Med Interne (Paris); 2000 May; 151 Suppl 1():1S13-8. PubMed ID: 10896983
[TBL] [Abstract][Full Text] [Related]
2. Immunomodulation of autoimmune and inflammatory diseases with intravenous immunoglobulin.
Ephrem A; Misra N; Hassan G; Dasgupta S; Delignat S; Duong Van Huyen JP; Chamat S; Prost F; Lacroix-Desmazes S; Kavery SV; Kazatchkine MD
Clin Exp Med; 2005 Dec; 5(4):135-40. PubMed ID: 16362793
[TBL] [Abstract][Full Text] [Related]
3. [Old and current aspects of intravenous immunoglobulin therapy].
Nydegger U
Schweiz Med Wochenschr; 1994 Jan; 124(1-2):5-25. PubMed ID: 8296191
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of action of intravenous immune globulin in immune-mediated diseases.
Mouthon L; Kaveri SV; Spalter SH; Lacroix-Desmazes S; Lefranc C; Desai R; Kazatchkine MD
Clin Exp Immunol; 1996 May; 104 Suppl 1():3-9. PubMed ID: 8625540
[TBL] [Abstract][Full Text] [Related]
5. [Use of intravenous polyclonal immunoglobulins in autoimmune and inflammatory disorders].
Graff-Dubois S; Sibéril S; Elluru S; Negi VS; Delignat S; Mouthon L; Lacroix-Desmazes S; Kazatchkine MD; Bayary J; Kaveri SV
Transfus Clin Biol; 2007 May; 14(1):63-8. PubMed ID: 17498995
[TBL] [Abstract][Full Text] [Related]
6. Intravenous immunoglobulin in autoimmune and inflammatory diseases: more than mere transfer of antibodies.
Sibéril S; Elluru S; Negi VS; Ephrem A; Misra N; Delignat S; Bayary J; Lacroix-Desmazes S; Kazatchkine MD; Kaveri SV
Transfus Apher Sci; 2007 Aug; 37(1):103-7. PubMed ID: 17765663
[TBL] [Abstract][Full Text] [Related]
7. Immunomodulation with intravenous immunoglobulin.
Hall PD
Pharmacotherapy; 1993; 13(6):564-73. PubMed ID: 8302679
[TBL] [Abstract][Full Text] [Related]
8. Monocyte-macrophage system as targets for immunomodulation by intravenous immunoglobulin.
Rhoades CJ; Williams MA; Kelsey SM; Newland AC
Blood Rev; 2000 Mar; 14(1):14-30. PubMed ID: 10805258
[TBL] [Abstract][Full Text] [Related]
9. Immune modulating effects of intravenous immunoglobulin (IVIg) in autoimmune diseases.
Mouthon L; Kaveri S; Kazatchkine M
Transfus Sci; 1994 Dec; 15(4):393-408. PubMed ID: 10155557
[TBL] [Abstract][Full Text] [Related]
10. The IgG molecule as a biological immune response modifier: mechanisms of action of intravenous immune serum globulin in autoimmune and inflammatory disorders.
Ballow M
J Allergy Clin Immunol; 2011 Feb; 127(2):315-23; quiz 324-5. PubMed ID: 21185071
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of various intravenous immunoglobulin therapy protocols in autoimmune and chronic inflammatory disorders.
Gürcan HM; Ahmed AR
Ann Pharmacother; 2007 May; 41(5):812-23. PubMed ID: 17440006
[TBL] [Abstract][Full Text] [Related]
12. [Intravenous immunoglobulin therapy].
Mouthon L
Rev Prat; 2005 May; 55(10):1049-56. PubMed ID: 16097244
[TBL] [Abstract][Full Text] [Related]
13. Intravenous immunoglobulin therapy for autoimmune diseases.
Arnson Y; Shoenfeld Y; Amital H
Autoimmunity; 2009 Sep; 42(6):553-60. PubMed ID: 19657774
[TBL] [Abstract][Full Text] [Related]
14. Intravenous immunoglobulin: an emerging treatment for immune-mediated skin diseases.
Rütter A; Luger TA
Curr Opin Investig Drugs; 2002 May; 3(5):713-9. PubMed ID: 12090544
[TBL] [Abstract][Full Text] [Related]
15. [Current developments in the use of intravenous immunoglobulins].
Bardare M; Dellepiane RM
Minerva Pediatr; 1991 Nov; 43(11):665-74. PubMed ID: 1791793
[TBL] [Abstract][Full Text] [Related]
16. [Immunoregulatory mechanisms of action of intravenous gammaglobulin in Kawasaki syndrome].
Marcinkiewicz J; Szymanowska Z; Mazurek A
Przegl Lek; 1998; 55(11):611-3. PubMed ID: 10216377
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of intravenous immunoglobulin action in immune thrombocytopenic purpura.
Jin F; Balthasar JP
Hum Immunol; 2005 Apr; 66(4):403-10. PubMed ID: 15866704
[TBL] [Abstract][Full Text] [Related]
18. Intravenous immunoglobulin in neurological disorders: a mechanistic perspective.
Misra N; Bayry J; Ephrem A; Dasgupta S; Delignat S; Duong Van Huyen JP; Prost F; Lacroix-Desmazes S; Nicoletti A; Kazatchkine MD; Kaveri SV
J Neurol; 2005 May; 252 Suppl 1():I1-6. PubMed ID: 15959666
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic intravenous immunoglobulins.
Lemieux R; Bazin R; Néron S
Mol Immunol; 2005 May; 42(7):839-48. PubMed ID: 15829272
[TBL] [Abstract][Full Text] [Related]
20. [Use of intravenous immunoglobulins in pediatrics].
Duse M; Plebani A; Crispino P; Ugazio AG
Pediatr Med Chir; 1991; 13(2):117-25. PubMed ID: 1896376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
